Nuclear Medicine: Page 3

PET imaging predicts long-term outcomes in Parkinson's disease

By Will Morton

PET brain imaging in individuals with early Parkinson's disease can show which patients are at higher risk of long-term effects, according to a study by researchers in Italy.

September 11, 2023

FAPI-PET/CT may improve treatment of cancer patients

By Will Morton

Gallium-68 (Ga-68) FAPI-PET/CT imaging -- a highly accurate experimental approach for detecting cancer -- may further improve outcomes for patients undergoing radiation therapy, according to a recent analysis by German researchers.

September 11, 2023

Eczacıbaşı-Monrol to expand Lu-177 production

By AuntMinnie.com staff writers

Turkish radiopharmaceutical company Eczacıbaşı-Monrol plans to expand its Lutetium-177 (Lu-177) production capacity.

September 10, 2023

PET/CT-based model predicts prostate cancer in the 'PSA grey zone'

By Will Morton

Combining PET/CT with traditional clinical risk factors can detect prostate cancer in cases considered borderline based on prostate-specific antigen (PSA) levels -- in other words, cases in the "PSA grey zone," according to a group in Hunan, China.

September 10, 2023

PET reveals link between heart health and brain metabolism

By Will Morton

A PET study suggests that maintaining cardiovascular health during midlife can help reduce the risk of neurodegenerative disease later in life, according to a group in Spain.

September 6, 2023

Telix touts studies at EANM 2023

By AuntMinnie.com staff writers

Telix Pharmaceuticals is highlighting studies set to be presented at the European Association of Nuclear Medicine meeting to be held September 9-13 in Vienna.

September 5, 2023

Actinium to present three abstracts at SOHO 2023

By AuntMinnie.com staff writers

Radiotherapy developer Actinium Pharmaceuticals will present three abstracts accepted for poster presentation at the Society of Hematologic Oncology (SOHO) 2023 annual meeting in Houston, TX, between September 6 and 9.

August 30, 2023

TerraPower, PanTera sign agreement for Ac-225 production

By AuntMinnie.com staff writers

TerraPower Isotopes and PanTera signed a strategic collaboration that they say will increase the global availability of actinium-225 (Ac-225), a radioisotope that may prove able to treat a large variety of cancer indications.

August 30, 2023

Staff safety at risk during Y-90 radioembolizations

By Will Morton

Contamination during yttrium-90 (Y-90) radioembolization procedures can lead to significant radiation exposure for medical personnel, according to a study published August 16 in the Journal of Nuclear Medicine Technology.

August 22, 2023

AI developed for SPECT kidney imaging in children

By Will Morton

An AI model based on SPECT images has the potential to help nuclear medicine physicians identify kidney defects in children, according to a research group in Taiwan.

August 16, 2023

AI outperforms clinical scores in high-risk lymphoma patients

By Will Morton

Researchers have developed an AI algorithm for reading FDG-PET/CT scans that outperforms standard clinical scores used to identify high-risk lymphoma patients, according to a study published August 12 in Scientific Reports.

August 15, 2023

AI could help evaluate brain tumors on PET

By Will Morton

A group in Germany has developed an AI model for PET imaging that could help clinicians determine whether patients are responding to brain tumor treatments, according to a study published August 10 in the Journal of Nuclear Medicine.

August 14, 2023

Previous Page

Page 3 of 436

Next Page